Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis
Condition(s):Lupus NephritisLast Updated:November 20, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Lupus NephritisLast Updated:November 20, 2019Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:April 8, 2021Recruiting
Condition(s):HemophiliaLast Updated:April 9, 2014Unknown status
Condition(s):Acute on Chronic Hepatic FailureLast Updated:February 28, 2024Terminated
Condition(s):Heart Failure, SystolicLast Updated:October 6, 2023Enrolling by invitation
Condition(s):Crohn’s Disease; Fistula; Anal Fistula; Pouch, Ileal; Pouches, IleoanalLast Updated:April 5, 2022Withdrawn
Condition(s):Interstitial Lung Disease; Connective Tissue DiseasesLast Updated:April 7, 2023Completed
Condition(s):Parkinson’s DiseaseLast Updated:November 29, 2023Completed
Condition(s):Prostate CancerLast Updated:July 16, 2018Terminated
Condition(s):Pouchitis; Crohn’s Disease; Ulcerative Colitis Chronic; Inflammatory Bowel Diseases; Pouch, IlealLast Updated:October 13, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.